{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:22:16Z","timestamp":1762928536789,"version":"build-2065373602"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lumind\/Research Down Syndrome and Lejeune Foundations"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.brainres.2017.09.035","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T09:46:12Z","timestamp":1510134372000},"page":"3-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"1702","author":[{"given":"Ravikumar","family":"Ponnusamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Windy","family":"McNerney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrzad","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-3280","authenticated-orcid":false,"given":"Ahmad","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2017.09.035_b0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s002130050225","article-title":"Destruction of central noradrenergic neurones with DSP4 impairs the acquisition of temporal discrimination but does not affect memory for duration in a delayed conditional discrimination task","volume":"130","author":"al-Zahrani","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2017.09.035_b0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2396(200002)35:2<151::AID-SYN8>3.0.CO;2-P","article-title":"Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity","volume":"35","author":"Albensi","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.brainres.2017.09.035_b0015","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/nan.12386","article-title":"Locus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology","volume":"43","author":"Andres-Benito","year":"2017","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.brainres.2017.09.035_b0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.neuropharm.2017.01.010","article-title":"Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer\u2019s disease using a biased and selective beta-1 adrenergic receptor partial agonist","volume":"116","author":"Ardestani","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2017.09.035_b0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00213-009-1537-0","article-title":"Dissociable effects of noradrenaline, dopamine, and serotonin uptake blockade on stop task performance in rats","volume":"205","author":"Bari","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2017.09.035_b0030","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/jcbfm.2012.115","article-title":"The locus coeruleus-norepinephrine network optimizes coupling of cerebral blood volume with oxygen demand","volume":"32","author":"Bekar","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.brainres.2017.09.035_b0035","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1523\/JNEUROSCI.4814-07.2008","article-title":"Dynamics of the microglial\/amyloid interaction indicate a role in plaque maintenance","volume":"28","author":"Bolmont","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002093-198701040-00005","article-title":"Neuronal degeneration in locus ceruleus and cortical correlates of Alzheimer disease","volume":"1","author":"Bondareff","year":"1987","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.brainres.2017.09.035_b0045","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-010-0789-4","article-title":"The pathological process underlying Alzheimer\u2019s disease in individuals under thirty","volume":"121","author":"Braak","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.035_b0050","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0055","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1038\/srep04618","article-title":"Pharmacological targeting of the beta-amyloid precursor protein intracellular domain","volume":"4","author":"Branca","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2017.09.035_b0060","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/1570159X12666140828220938","article-title":"Noradrenergic regulation of glial activation: molecular mechanisms and therapeutic implications","volume":"12","author":"Braun","year":"2014","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.brainres.2017.09.035_b0065","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1074\/jbc.M706579200","article-title":"NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42","volume":"283","author":"Buggia-Prevot","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2017.09.035_b0070","doi-asserted-by":"crossref","first-page":"E1479","DOI":"10.1152\/ajpendo.00664.2007","article-title":"Alpha- and beta-adrenergic receptors: Ahlquist\u2019s landmark hypothesis of a single mediator with two receptors","volume":"293","author":"Bylund","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.brainres.2017.09.035_b0075","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2017.09.035_b0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/alzrt175","article-title":"Targeting norepinephrine in mild cognitive impairment and Alzheimer\u2019s disease","volume":"5","author":"Chalermpalanupap","year":"2013","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.brainres.2017.09.035_b0085","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/cne.902870308","article-title":"Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson\u2019s disease with and without dementia and depression","volume":"287","author":"Chan-Palay","year":"1989","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3171\/jns.1975.43.1.0032","article-title":"Catecholamine content of cerebral tissue after occlusion or manipulation of middle cerebral artery in cats","volume":"43","author":"Cohen","year":"1975","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.brainres.2017.09.035_b0095","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1523\/JNEUROSCI.21-04-01179.2001","article-title":"beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis","volume":"21","author":"Combs","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.pnpbp.2009.03.038","article-title":"Entorhinal cortex and cognition","volume":"33","author":"Coutureau","year":"2009","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2017.09.035_b0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1748-1716.1964.tb10446.x","article-title":"Ascending systems of catecholamine neurons from the lower brain stem","volume":"62","author":"Dahlstroem","year":"1964","journal-title":"Acta Physiol. Scand."},{"unstructured":"Dang, V., M.K., Moghadam, S., Medina, B., Lin, B., Patel, D., 2012. Improving noradrenergic signaling in the treatment of cognitive dysfunction in the Ts65dn mouse model of down syndrome. In: Society For Neuroscience.","key":"10.1016\/j.brainres.2017.09.035_b0110"},{"issue":"3","key":"10.1016\/j.brainres.2017.09.035_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2013.05.024","article-title":"Formoterol, a long-acting \u03b22 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome","volume":"75","author":"Dang","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2017.09.035_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2017.01.015","article-title":"A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature","volume":"53","author":"Dardiotis","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0125","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/gim.2016.127","article-title":"Estimation of the number of people with Down syndrome in the United States","volume":"19","author":"de Graaf","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.brainres.2017.09.035_b0130","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neuroscience.2004.08.018","article-title":"Disruption of reconsolidation but not consolidation of auditory fear conditioning by noradrenergic blockade in the amygdala","volume":"129","author":"Debiec","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2017.09.035_b0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3233\/JAD-140783","article-title":"Serum MHPG strongly predicts conversion to Alzheimer\u2019s disease in behaviorally characterized subjects with Down syndrome","volume":"43","author":"Dekker","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2017.09.035_b0140","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.0409848102","article-title":"Remembering one year later: role of the amygdala and the medial temporal lobe memory system in retrieving emotional memories","volume":"102","author":"Dolcos","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.035_b0145","first-page":"54","article-title":"Observations on an ethnic classification of idiots. 1866","volume":"33","author":"Down","year":"1995","journal-title":"Ment. Retard."},{"key":"10.1016\/j.brainres.2017.09.035_b0150","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1471-4159.1993.tb13425.x","article-title":"Norepinephrine suppresses inducible nitric oxide synthase activity in rat astroglial cultures","volume":"60","author":"Feinstein","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.09.035_b0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-0186(02)00049-9","article-title":"Noradrenergic regulation of inflammatory gene expression in brain","volume":"41","author":"Feinstein","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2017.09.035_b0160","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.neubiorev.2012.03.008","article-title":"The role of metaplasticity mechanisms in regulating memory destabilization and reconsolidation","volume":"36","author":"Finnie","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.brainres.2017.09.035_b0165","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/archneur.62.10.noc50112","article-title":"Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults","volume":"62","author":"Fishel","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF00227813","article-title":"Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils","volume":"84","author":"Frackowiak","year":"1992","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.brainres.2017.09.035_b0175","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3940(98)00003-2","article-title":"Adrenergic agonists suppress the proliferation of microglia through beta 2-adrenergic receptor","volume":"242","author":"Fujita","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.09.035_b0180","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaac.2010.06.015","article-title":"Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors","volume":"49","author":"Gamo","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.brainres.2017.09.035_b0185","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0190","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1021\/bi00198a006","article-title":"Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties","volume":"33","author":"Green","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.brainres.2017.09.035_b0195","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","article-title":"Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease","volume":"86","author":"Griffin","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.035_b0200","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","article-title":"Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer\u2019s disease","volume":"28","author":"Grudzien","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neurobiolaging.2007.05.020","article-title":"Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice","volume":"30","author":"Guerin","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neuint.2010.03.001","article-title":"The norepinephrine transporter (NET) radioligand (S, S)-[18F]FMeNER-D2 shows significant decreases in NET density in the human brain in Alzheimer\u2019s disease: a post-mortem autoradiographic study","volume":"56","author":"Gulyas","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2017.09.035_b0215","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1523\/JNEUROSCI.22-07-02434.2002","article-title":"Noradrenergic depletion potentiates beta-amyloid-induced cortical inflammation: implications for Alzheimer\u2019s disease","volume":"22","author":"Heneka","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b9000","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0220","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.0909586107","article-title":"Locus ceruleus controls Alzheimer\u2019s disease pathology by modulating microglial functions through norepinephrine","volume":"107","author":"Heneka","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.035_b0225","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.neuint.2010.03.019","article-title":"Adrenoceptors in brain: cellular gene expression and effects on astrocytic metabolism and [Ca(2+)]i","volume":"57","author":"Hertz","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2017.09.035_b0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"Suppl. 1","key":"10.1016\/j.brainres.2017.09.035_b0235","first-page":"S295","article-title":"The neuroimmune system in Alzheimer\u2019s disease: the glass is half full","volume":"33","author":"Hickman","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2017.09.035_b0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2008-1064034","article-title":"Aphasia or dementia: the cautionary tale of Dr. JJ","volume":"19","author":"Holland","year":"1998","journal-title":"Semin. Speech Lang."},{"key":"10.1016\/j.brainres.2017.09.035_b0245","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/j.1460-2075.1994.tb06291.x","article-title":"Selective ectodomain phosphorylation and regulated cleavage of beta-amyloid precursor protein","volume":"13","author":"Hung","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.brainres.2017.09.035_b0250","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.6474172","article-title":"Alzheimer\u2019s disease: cell-specific pathology isolates the hippocampal formation","volume":"225","author":"Hyman","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.brainres.2017.09.035_b0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuint.2015.07.010","article-title":"Anti-inflammatory effects of noradrenaline on LPS-treated microglial cells: suppression of NFkappaB nuclear translocation and subsequent STAT1 phosphorylation","volume":"90","author":"Ishii","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainres.2017.09.035_b0260","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0304-3940(83)90171-4","article-title":"Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer\u2019s type","volume":"39","author":"Iversen","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.09.035_b0265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0140-6736(59)91892-6","article-title":"The somatic chromosomes in mongolism","volume":"1","author":"Jacobs","year":"1959","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2017.09.035_b0270","series-title":"Highly Selective Neurotoxins: Basic and Clinical Applications","article-title":"2-Chloroethylamines (DSP4 and xylamine)","author":"Jaim-Etcheverry","year":"1998"},{"key":"10.1016\/j.brainres.2017.09.035_b0275","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuroscience.2010.11.052","article-title":"Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP\/PS1 transgenic mice","volume":"176","author":"Jardanhazi-Kurutz","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2017.09.035_b0280","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1084\/jem.20142322","article-title":"TREM2 deficiency eliminates TREM2\u202f+\u202finflammatory macrophages and ameliorates pathology in Alzheimer\u2019s disease mouse models","volume":"212","author":"Jay","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.brainres.2017.09.035_b0285","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00213-008-1181-0","article-title":"Effects of atomoxetine and methylphenidate on performance of a lateralized reaction time task in rats","volume":"202","author":"Jentsch","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2017.09.035_b0290","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0091-3057(03)00073-X","article-title":"Norepinephrine regulates locomotor hyperactivity in the mouse mutant coloboma","volume":"75","author":"Jones","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.brainres.2017.09.035_b0295","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(02)01814-9","article-title":"Stimulation of beta-adrenoceptors activates astrocytes and provides neuroprotection","volume":"446","author":"Junker","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.brainres.2017.09.035_b0300","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.neurobiolaging.2006.06.003","article-title":"Noradrenaline deficiency in brain increases beta-amyloid plaque burden in an animal model of Alzheimer\u2019s disease","volume":"28","author":"Kalinin","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0305","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2011.04.012","article-title":"The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer\u2019s disease","volume":"33","author":"Kalinin","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0310","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fnmol.2015.00069","article-title":"NF-KappaB in long-term memory and structural plasticity in the adult mammalian brain","volume":"8","author":"Kaltschmidt","year":"2015","journal-title":"Front. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.brainres.2017.09.035_b0315","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.neuroscience.2008.11.001","article-title":"Effect of reversible inactivation of locus ceruleus on spatial reference and working memory","volume":"158","author":"Khakpour-Taleghani","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2017.09.035_b0320","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ijdevneu.2003.08.001","article-title":"Alterations in cholinergic and non-cholinergic neurotransmitter receptor densities in transgenic Tg2576 mouse brain with beta-amyloid plaque pathology","volume":"21","author":"Klingner","year":"2003","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0325","doi-asserted-by":"crossref","first-page":"11848","DOI":"10.1523\/JNEUROSCI.2985-10.2010","article-title":"Norepinephrine promotes microglia to uptake and degrade amyloid beta peptide through upregulation of mouse formyl peptide receptor 2 and induction of insulin-degrading enzyme","volume":"30","author":"Kong","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0330","doi-asserted-by":"crossref","first-page":"8845","DOI":"10.1523\/JNEUROSCI.4027-13.2014","article-title":"Ear2 deletion causes early memory and learning deficits in APP\/PS1 mice","volume":"34","author":"Kummer","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0335","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2217\/fnl.12.6","article-title":"Clearance of amyloid-beta peptides by microglia and macrophages: the issue of what, when and where","volume":"7","author":"Lai","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0340","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archneur.1989.00520440031017","article-title":"A prospective study of Alzheimer disease in Down syndrome","volume":"46","author":"Lai","year":"1989","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0345","first-page":"1721","article-title":"Study of somatic chromosomes from 9 mongoloid children","volume":"248","author":"Lejeune","year":"1959","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"10.1016\/j.brainres.2017.09.035_b0350","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neuron.2012.12.040","article-title":"Environmental novelty activates beta2-adrenergic signaling to prevent the impairment of hippocampal LTP by Abeta oligomers","volume":"77","author":"Li","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2017.09.035_b0355","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/svn-2016-000012","article-title":"Neurotransmitter receptors on microglia","volume":"1","author":"Liu","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0360","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.1991.tb00220.x","article-title":"Analysis of monoamines in the cerebrospinal fluid of Chinese patients with Alzheimer\u2019s disease","volume":"640","author":"Liu","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.brainres.2017.09.035_b0365","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neulet.2008.03.018","article-title":"Association study of a functional catechol-O-methyltransferase polymorphism and executive function in elderly males without dementia","volume":"436","author":"Liu","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.09.035_b0370","doi-asserted-by":"crossref","first-page":"13805","DOI":"10.1523\/JNEUROSCI.4218-08.2008","article-title":"Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer\u2019s disease","volume":"28","author":"Liu","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0375","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3233\/JAD-2010-101218","article-title":"A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model","volume":"23","author":"Lockrow","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2017.09.035_b0380","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1503\/jpn.120111","article-title":"Propranolol\u2019s effects on the consolidation and reconsolidation of long-term emotional memory in healthy participants: a meta-analysis","volume":"38","author":"Lonergan","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0385","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/jnr.20481","article-title":"Norepinephrine protects cortical neurons against microglial-induced cell death","volume":"81","author":"Madrigal","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0390","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/ars.2006.8.885","article-title":"Effects of noradrenaline on neuronal NOS2 expression and viability","volume":"8","author":"Madrigal","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.brainres.2017.09.035_b0395","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/j.1471-4159.2007.04888.x","article-title":"Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta","volume":"103","author":"Madrigal","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2017.09.035_b0400","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1046\/j.1460-9568.2003.02854.x","article-title":"Activation of the amygdalo-entorhinal pathway in fear-conditioning in rat","volume":"18","author":"Majak","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0405","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1192\/bjp.136.6.533","article-title":"Changes in the monoamine containing neurones of the human CNS in senile dementia","volume":"136","author":"Mann","year":"1980","journal-title":"Br. J. Psychiatry"},{"issue":"Pt 2","key":"10.1016\/j.brainres.2017.09.035_b0410","first-page":"125","article-title":"Pathological evidence for neurotransmitter deficits in Down\u2019s syndrome of middle age","volume":"29","author":"Mann","year":"1985","journal-title":"J. Ment. Defic. Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0415","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1523\/JNEUROSCI.15-01-00152.1995","article-title":"Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human","volume":"15","author":"Mantyh","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0420","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson\u2019s disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"10.1016\/j.brainres.2017.09.035_b0425","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-3223(01)01235-5","article-title":"Noradrenergic changes, aggressive behavior, and cognition in patients with dementia","volume":"51","author":"Matthews","year":"2002","journal-title":"Biol. Psychiatry"},{"doi-asserted-by":"crossref","unstructured":"McNerney, M.W., Mobley, W.C., Salehi. Down Syndrome or Trisomy 21. Reference Module in Neuroscience and Biobehavioral Psychology, Elsevier, 2017.","key":"10.1016\/j.brainres.2017.09.035_b0430","DOI":"10.1016\/B978-0-12-809324-5.01963-5"},{"key":"10.1016\/j.brainres.2017.09.035_b0435","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nn1110","article-title":"NF-kappa B functions in synaptic signaling and behavior","volume":"6","author":"Meffert","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0440","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1523\/JNEUROSCI.4001-13.2014","article-title":"Reconsolidation and extinction are dissociable and mutually exclusive processes: behavioral and molecular evidence","volume":"34","author":"Merlo","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2017.09.035_b0445","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0028-3908(02)00211-3","article-title":"Effects of norepinephrine on rat cultured microglial cells that express \u03b11, \u03b12, \u03b21 and \u03b22 adrenergic receptors","volume":"43","author":"Mori","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.brainres.2017.09.035_b0450","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.neurobiolaging.2004.05.010","article-title":"Glia and their cytokines in progression of neurodegeneration","volume":"26","author":"Mrak","year":"2005","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0455","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mehy.2013.11.016","article-title":"Uptake of environmental toxicants by the locus ceruleus: a potential trigger for neurodegenerative, demyelinating and psychiatric disorders","volume":"82","author":"Pamphlett","year":"2014","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.brainres.2017.09.035_b0460","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.tips.2008.01.002","article-title":"The neuropharmacology of impulsive behaviour","volume":"29","author":"Pattij","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.brainres.2017.09.035_b0465","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-011-2405-2","article-title":"On the improvement of inhibitory response control and visuospatial attention by indirect and direct adrenoceptor agonists","volume":"219","author":"Pattij","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.brainres.2017.09.035_b0470","doi-asserted-by":"crossref","first-page":"103780","DOI":"10.1155\/2014\/103780","article-title":"Potential benefits of therapeutic use of beta2-adrenergic receptor agonists in neuroprotection and Parkinsonmus disease","volume":"2014","author":"Peterson","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0475","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/1567205012666150921095924","article-title":"Noradrenergic system in Down syndrome and Alzheimer\u2019s disease a target for therapy","volume":"13","author":"Phillips","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0480","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0006-8993(01)02174-6","article-title":"beta-adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia","volume":"899","author":"Prinz","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0485","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer\u2019s disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0490","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1152\/jn.00374.2011","article-title":"Beta2-adrenergic receptor supports prolonged theta tetanus-induced LTP","volume":"107","author":"Qian","year":"2012","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.brainres.2017.09.035_b0495","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.1002449","article-title":"Beta2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway","volume":"186","author":"Qian","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.brainres.2017.09.035_b0500","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2005.07.018","article-title":"High cholesterol diet results in increased expression of interleukin-6 and caspase-1 in the brain of apolipoprotein E knockout and wild type mice","volume":"169","author":"Rahman","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.brainres.2017.09.035_b0505","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-510X(88)90179-7","article-title":"A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer\u2019s disease","volume":"84","author":"Reinikainen","year":"1988","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.brainres.2017.09.035_b0510","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0140-6736(85)92666-2","article-title":"Alzheimer-like brain monoamine deficits in adults with Down\u2019s syndrome","volume":"2","author":"Reynolds","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.brainres.2017.09.035_b0515","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mrdd.20164","article-title":"Using mouse models to explore genotype-phenotype relationship in Down syndrome","volume":"13","author":"Salehi","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.brainres.2017.09.035_b0520","series-title":"Pharmacological Mechanisms in Alzheimer\u2019s Therapeutics","article-title":"Cholinergic neurodegeneration in Alzheimer\u2019s disease: basis for nerve growth factor therapy","author":"Salehi","year":"2007"},{"key":"10.1016\/j.brainres.2017.09.035_b0525","series-title":"The New Encyclopedia of Neuroscience","article-title":"Down syndrome\/trisomy 21","author":"Salehi","year":"2009"},{"key":"10.1016\/j.brainres.2017.09.035_b0530","doi-asserted-by":"crossref","first-page":"7ra17","DOI":"10.1126\/scitranslmed.3000258","article-title":"Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome","volume":"1","author":"Salehi","year":"2009","journal-title":"Sci. Transl. Med."},{"issue":"Pt 3","key":"10.1016\/j.brainres.2017.09.035_b0535","first-page":"259","article-title":"Cerebrospinal fluid monoamines in Down\u2019s syndrome adults at different ages","volume":"31","author":"Schapiro","year":"1987","journal-title":"J. Ment. Defic. Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0540","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.1231357","article-title":"Prediction error governs pharmacologically induced amnesia for learned fear","volume":"339","author":"Sevenster","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.brainres.2017.09.035_b0545","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","article-title":"In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis","volume":"17","author":"Sheng","year":"1996","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0550","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","article-title":"Monoaminergic neuropathology in Alzheimer\u2019s disease","volume":"151","author":"Simic","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.brainres.2017.09.035_b0555","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00702-007-0830-5","article-title":"Effects of the noradrenergic neurotoxin DSP4 on spatial memory in the rat","volume":"115","author":"Sontag","year":"2008","journal-title":"J. Neural. Transm. (Vienna)"},{"key":"10.1016\/j.brainres.2017.09.035_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00198","article-title":"Cellular and molecular characterization of microglia: a unique immune cell population","volume":"8","author":"Sousa","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.brainres.2017.09.035_b0565","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neuron.2004.12.044","article-title":"Spatial memory in the rat requires the dorsolateral band of the entorhinal cortex","volume":"45","author":"Steffenach","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2017.09.035_b0570","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1172\/JCI36532","article-title":"Nuanced roles of cytokines in three major human brain disorders","volume":"118","author":"Steinman","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.brainres.2017.09.035_b0575","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0304-3940(95)12256-7","article-title":"Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients","volume":"203","author":"Storga","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2017.09.035_b0580","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2567.1997.00137.x","article-title":"Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia","volume":"90","author":"Szabo","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.brainres.2017.09.035_b0585","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jnr.10399","article-title":"Existence of functional beta1- and beta2-adrenergic receptors on microglia","volume":"70","author":"Tanaka","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0590","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3233\/JAD-142682","article-title":"Turning on the light within: subcortical nuclei of the isodentritic core and their role in Alzheimer\u2019s disease pathogenesis","volume":"46","author":"Theofilas","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.brainres.2017.09.035_b0595","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jalz.2016.06.2362","article-title":"Locus coeruleus volume and cell population changes during Alzheimer\u2019s disease progression: a stereological study in human postmortem brains with potential implication for early-stage biomarker discovery","volume":"13","author":"Theofilas","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.brainres.2017.09.035_b0600","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/glia.440110411","article-title":"Downregulation of in vitro neurotoxicity of brain macrophages by prostaglandin E2 and a beta-adrenergic agonist","volume":"11","author":"Thery","year":"1994","journal-title":"Glia"},{"key":"10.1016\/j.brainres.2017.09.035_b0605","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0306-4522(96)00592-1","article-title":"Topographical organization of projections from the entorhinal cortex to the striatum of the rat","volume":"78","author":"Totterdell","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2017.09.035_b9010","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.neubiorev.2013.05.008","article-title":"Ascending monoaminergic systems alterations in Alzheimer\u2019s disease translating basic science into clinical care","volume":"37","author":"Trillo","year":"2013","journal-title":"Neurosci Biobehav Rev."},{"key":"10.1016\/j.brainres.2017.09.035_b0610","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/sj.mp.4001763","article-title":"Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine","volume":"11","author":"Tzavara","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.brainres.2017.09.035_b0615","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.actpsy.2007.10.004","article-title":"The role of the noradrenergic system in emotional memory","volume":"127","author":"van Stegeren","year":"2008","journal-title":"Acta Psychol. (Amst)"},{"key":"10.1016\/j.brainres.2017.09.035_b0620","doi-asserted-by":"crossref","first-page":"31852","DOI":"10.1074\/jbc.M111.244335","article-title":"Amyloid beta peptide-(1\u201342) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons","volume":"286","author":"Wang","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.brainres.2017.09.035_b0625","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.neurobiolaging.2007.12.004","article-title":"Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP\/PKA signalling pathway","volume":"30","author":"Wang","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2017.09.035_b0630","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.410170310","article-title":"Occurrence of neuropathological changes and dementia of Alzheimer\u2019s disease in Down\u2019s syndrome","volume":"17","author":"Wisniewski","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0635","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1073\/pnas.0402851101","article-title":"beta-Arrestin inhibits NF-kappaB activity by means of its interaction with the NF-kappaB inhibitor IkappaBalpha","volume":"101","author":"Witherow","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2017.09.035_b0640","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1111\/j.1440-1681.2010.05426.x","article-title":"Evidence for suppression of spinal glial activation by dexmedetomidine in a rat model of monoarthritis","volume":"37","author":"Xu","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.brainres.2017.09.035_b0645","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.expneurol.2012.05.008","article-title":"Norepinephrine differentially modulates the innate inflammatory response provoked by amyloid-beta peptide via action at beta-adrenoceptors and activation of cAMP\/PKA pathway in human THP-1 macrophages","volume":"236","author":"Yang","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.brainres.2017.09.035_b0650","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","article-title":"TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia","volume":"91","author":"Yeh","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2017.09.035_b0655","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.brainres.2008.03.019","article-title":"Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer\u2019s disease susceptibility","volume":"1210","author":"Yu","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2017.09.035_b0660","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ddrr.1128","article-title":"Atypical aging in Down syndrome","volume":"18","author":"Zigman","year":"2013","journal-title":"Dev. Disabil. Res. Rev."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899317304948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:02:05Z","timestamp":1762102925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899317304948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":134,"alternative-id":["S0006899317304948"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2017.09.035","relation":{},"ISSN":["0006-8993"],"issn-type":[{"type":"print","value":"0006-8993"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2017.09.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}